Dosage protocol · Brain Health & Nootropics
Cerebrolysin 60 mg
Typical daily range: 20–32 mg once daily (gradual titration); split doses for >20 mg.
- Reconstitute: Add 3.0 mL bacteriostatic water → 20 mg/mL concentration.
- Typical daily range: 20–32 mg once daily (gradual titration); split doses for >20 mg.
- Easy measuring: At 20 mg/mL, 1 unit = 0.01 mL = 200 mcg (0.2 mg) on a U‑100 insulin syringe.
- Storage: Lyophilized at room temperature ≤25 °C (≤77 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 7 days; do not freeze.
BAC water3.0mL
Concentration20mg/mL
Per unit (0.01 mL)200mcg
Reconstitution
Cerebrolysin dosage chart
Cerebrolysin dosage chart
| Week | Dose | Draw |
|---|---|---|
| Week 1 | 20 mg20,000 mcg | 100 units × 11.0 mL |
| Week 2 | 24 mg24,000 mcg | 60 units PM0.6 mL |
| Week 3 | 28 mg28,000 mcg | 70 units PM0.7 mL |
| Week 4+ | 32 mg32,000 mcg | 80 units PM0.8 mL |
How much to draw
The Draw column shows exactly where to stop on a U-100 insulin syringe. Different vial size or dose? The calculator below recomputes it live.
Supplies needed
Supplies needed
Peptide vial
The lyophilized compound
Bacteriostatic water
For reconstitution
U-100 insulin syringes
One per injection
Alcohol swabs
Stopper + site each time
How it works
Cerebrolysin differs from most peptides covered on this site in that it isn't one defined amino-acid sequence — it is a biological mixture of low-molecular-weight peptide fragments and free amino acids derived from porcine (pig) brain tissue.[1] Sold outside the United States as an injectable solution, it has been studied for decades in neurological conditions including ischemic stroke, traumatic brain injury, vascular dementia, and Alzheimer's disease.[3] Because it is a biological mixture rather than a single synthesized molecule, its exact composition can vary somewhat by manufacturing batch.
Benefits & side effects
In dementia trials, Cerebrolysin has generally been described as well tolerated, with dizziness or vertigo the most common complaint. In one Alzheimer's disease trial, adverse events actually occurred slightly more often with placebo (73%) than with Cerebrolysin (64%), including headache, dizziness, and anxiety.[14] However, the 2023 Cochrane stroke review flagged a probable increase in non-fatal serious adverse events, and a published case report described a life-threatening anaphylactic reaction after intravenous administration.[3][24] Labeling used outside the United States lists several contraindications:
- Hypersensitivity to any component of the product
- Epilepsy or seizure disorders
- Severe renal impairment
Pregnancy, breastfeeding, and seizure history warrant clinician review given the limited data available.[2]
Calculator
Plan your own dose
Reconstituting a different vial size or targeting a different dose? Run the numbers.
1
Reconstitution
mg
mL
Concentration—
Per unit (0.01 mL)—
Per 10 units (0.1 mL)—
2
Your dose
Doses per vial—
Vial lasts—
Draw to
— units
=
—